vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.

Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $11.9M, roughly 1.2× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -342.3%, a 333.6% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 13.3%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.

ACNT vs GOSS — Head-to-Head

Bigger by revenue
GOSS
GOSS
1.2× larger
GOSS
$13.8M
$11.9M
ACNT
Growing faster (revenue YoY)
GOSS
GOSS
+33.8% gap
GOSS
47.1%
13.3%
ACNT
Higher net margin
ACNT
ACNT
333.6% more per $
ACNT
-8.8%
-342.3%
GOSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNT
ACNT
GOSS
GOSS
Revenue
$11.9M
$13.8M
Net Profit
$-1.0M
$-47.2M
Gross Margin
14.6%
Operating Margin
-21.0%
-333.6%
Net Margin
-8.8%
-342.3%
Revenue YoY
13.3%
47.1%
Net Profit YoY
-1.2%
-43.0%
EPS (diluted)
$-0.11
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
GOSS
GOSS
Q4 25
$11.9M
$13.8M
Q3 25
$19.7M
$13.3M
Q2 25
$18.7M
Q1 25
$24.7M
Q4 24
$10.5M
Q3 24
$20.9M
Q2 24
$21.5M
$95.8M
Q1 24
$28.0M
$0
Net Profit
ACNT
ACNT
GOSS
GOSS
Q4 25
$-1.0M
$-47.2M
Q3 25
$-2.1M
$-48.2M
Q2 25
$6.3M
Q1 25
$-2.3M
Q4 24
$-1.0M
Q3 24
$-6.2M
Q2 24
$-926.0K
$49.2M
Q1 24
$-5.5M
$-41.9M
Gross Margin
ACNT
ACNT
GOSS
GOSS
Q4 25
14.6%
Q3 25
29.7%
Q2 25
26.1%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACNT
ACNT
GOSS
GOSS
Q4 25
-21.0%
-333.6%
Q3 25
-4.1%
-369.4%
Q2 25
-14.4%
Q1 25
-4.2%
Q4 24
-25.4%
Q3 24
-9.4%
Q2 24
-8.6%
54.3%
Q1 24
-15.5%
Net Margin
ACNT
ACNT
GOSS
GOSS
Q4 25
-8.8%
-342.3%
Q3 25
-10.6%
-362.7%
Q2 25
33.7%
Q1 25
-9.3%
Q4 24
-9.8%
Q3 24
-29.5%
Q2 24
-4.3%
51.4%
Q1 24
-19.7%
EPS (diluted)
ACNT
ACNT
GOSS
GOSS
Q4 25
$-0.11
$-0.21
Q3 25
$-0.22
$-0.21
Q2 25
$0.65
Q1 25
$-0.23
Q4 24
$-0.11
Q3 24
$-0.61
Q2 24
$-0.09
$0.22
Q1 24
$-0.54
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
GOSS
GOSS
Cash + ST InvestmentsLiquidity on hand
$57.6M
$136.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.0M
$-122.8M
Total Assets
$111.9M
$172.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
GOSS
GOSS
Q4 25
$57.6M
$136.9M
Q3 25
$58.0M
$180.2M
Q2 25
$60.5M
Q1 25
$14.3M
Q4 24
$16.1M
Q3 24
$8.5M
Q2 24
$3.6M
$354.5M
Q1 24
$1.3M
$244.4M
Total Debt
ACNT
ACNT
GOSS
GOSS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACNT
ACNT
GOSS
GOSS
Q4 25
$87.0M
$-122.8M
Q3 25
$87.1M
$-82.3M
Q2 25
$89.7M
Q1 25
$91.2M
Q4 24
$93.5M
Q3 24
$94.7M
Q2 24
$101.0M
$81.5M
Q1 24
$102.0M
$26.7M
Total Assets
ACNT
ACNT
GOSS
GOSS
Q4 25
$111.9M
$172.2M
Q3 25
$119.9M
$208.8M
Q2 25
$122.6M
Q1 25
$152.5M
Q4 24
$147.3M
Q3 24
$148.6M
Q2 24
$158.2M
$373.4M
Q1 24
$161.0M
$259.4M
Debt / Equity
ACNT
ACNT
GOSS
GOSS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
GOSS
GOSS
Operating Cash FlowLast quarter
$266.0K
$-48.3M
Free Cash FlowOCF − Capex
$-196.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
GOSS
GOSS
Q4 25
$266.0K
$-48.3M
Q3 25
$1.3M
$-36.2M
Q2 25
$-1.4M
Q1 25
$-700.0K
Q4 24
$8.8M
Q3 24
$3.4M
Q2 24
$2.2M
$116.3M
Q1 24
$263.0K
$-52.3M
Free Cash Flow
ACNT
ACNT
GOSS
GOSS
Q4 25
$-196.0K
Q3 25
$695.0K
Q2 25
$-1.5M
Q1 25
$-1.0M
Q4 24
$8.4M
Q3 24
$3.1M
Q2 24
$1.9M
Q1 24
$25.0K
FCF Margin
ACNT
ACNT
GOSS
GOSS
Q4 25
-1.7%
Q3 25
3.5%
Q2 25
-8.3%
Q1 25
-4.1%
Q4 24
80.6%
Q3 24
15.1%
Q2 24
9.1%
Q1 24
0.1%
Capex Intensity
ACNT
ACNT
GOSS
GOSS
Q4 25
3.9%
0.0%
Q3 25
3.1%
0.0%
Q2 25
0.8%
Q1 25
1.3%
Q4 24
3.7%
Q3 24
1.3%
Q2 24
1.0%
0.0%
Q1 24
0.9%
Cash Conversion
ACNT
ACNT
GOSS
GOSS
Q4 25
Q3 25
Q2 25
-0.22×
Q1 25
Q4 24
Q3 24
Q2 24
2.36×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

GOSS
GOSS

Segment breakdown not available.

Related Comparisons